The Interface between Rheumatology and Dermatology
Although the division of medicine into specialties according to different systems is convenient, it is also artificial: the different systems interact and many diseases overlap both in their pathological features as well as their clinical expression. Many examples of such interactions are seen in the connective tissue disorders, where rheumatological and dermatological manifestations may be prominent features. In some of them the skin rash may be a diagnostic marker (e.g., systemic lupus erythematosus, dermatomyositis). Joint involvement can also be found in “primary” skin disorders such as psoriasis; certain infections can produce both skin and joint manifestations including a number of fairly common viral disorders as well as Lyme borelliosis and the acquired immune deficiency syndrome (A.I.D.S.) The skin may also be the major target of toxicity from a number of drugs, particularly those that are used in the management of rheumatic disorders.
KeywordsSystemic Lupus Erythematosus Infective Endocarditis Familial Mediterranean Fever Skin Rash Connective Tissue Disease
Unable to display preview. Download preview PDF.
- 7.Kilbourne EM, Philen RM, Kamb ML, Falk H. Tryptophan produced by Showa Denko and epidemic eosi-nophilia-myalgia syndrome. J Rheumatol (Suppl). 46: 81–88. 1996.Google Scholar
- 9.Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol. 127: 839–842. 1991.Google Scholar
- 16.Levy H. Chloroquine-induced pigmentation. Case reports. S. Afr Med J. 62: 735–737. 1982.Google Scholar
- 28.Majeed HA, Quabazard Z, Hijazi Z, Farwana S, Harshani F. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. QJ Med. 278: 607–616. 1990.Google Scholar
- 36.Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients with Raynaud’s phenomenon: a six year follow up with emphasis on the predictive value of antinu-clear antibodies as detected by immunoblotting. Ann Rheum Dis. 47: 634–641. 1988.PubMedCrossRefGoogle Scholar
- 38.Bynum WF. The Great Imitator: Syphilis in Historical Perspective. Medicine Int. 24: 12. 1996.Google Scholar
- 44.Ribard P, Kahn MF. Rheumatological side effects of quinolones. Clin Rheumatol. 5: 175–191. 1991.Google Scholar
- 49.Lin RY. Unusual autoimmune manifestations in furosemide-associated hypersensitivity angiitis. NY State J Med. 88: 439–440. 1988.Google Scholar